Global Beta-Nicotinamide Mononucleotide (NMN) Market Growth 2024-2030

Global Beta-Nicotinamide Mononucleotide (NMN) Market Growth 2024-2030

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

The global Beta-Nicotinamide Mononucleotide (NMN) market size is projected to grow from US$ 401 million in 2024 to US$ 763 million in 2030; it is expected to grow at a CAGR of 11.3% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Beta-Nicotinamide Mononucleotide (NMN) Industry Forecast” looks at past sales and reviews total world Beta-Nicotinamide Mononucleotide (NMN) sales in 2023, providing a comprehensive analysis by region and market sector of projected Beta-Nicotinamide Mononucleotide (NMN) sales for 2024 through 2030. With Beta-Nicotinamide Mononucleotide (NMN) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Beta-Nicotinamide Mononucleotide (NMN) industry.

This Insight Report provides a comprehensive analysis of the global Beta-Nicotinamide Mononucleotide (NMN) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Beta-Nicotinamide Mononucleotide (NMN) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Beta-Nicotinamide Mononucleotide (NMN) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beta-Nicotinamide Mononucleotide (NMN) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Beta-Nicotinamide Mononucleotide (NMN).

Core manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirarailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production region, accounting for approximately 64% of the global market, followed by Japan and North America. In terms of product type, products with content ≥98% are the largest market segment, with a share of more than 99%. In terms of product application, the largest application market is health care products, with a share of approximately 99%.

This report presents a comprehensive overview, market shares, and growth opportunities of Beta-Nicotinamide Mononucleotide (NMN) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Content ≥98%
Content ＜98%

Segmentation by Application:
Health Care Products
Cosmetics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Key Questions Addressed in this Report

What is the 10-year outlook for the global Beta-Nicotinamide Mononucleotide (NMN) market?

What factors are driving Beta-Nicotinamide Mononucleotide (NMN) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Beta-Nicotinamide Mononucleotide (NMN) market opportunities vary by end market size?

How does Beta-Nicotinamide Mononucleotide (NMN) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.